Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

NCT00121602 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
446
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen